(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 4.53% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Sotera Health Co's revenue in 2025 is $1,150,379,000.On average, 10 Wall Street analysts forecast SHC's revenue for 2025 to be $332,673,990,859, with the lowest SHC revenue forecast at $322,446,609,415, and the highest SHC revenue forecast at $346,026,405,522. On average, 10 Wall Street analysts forecast SHC's revenue for 2026 to be $352,276,471,960, with the lowest SHC revenue forecast at $337,503,587,652, and the highest SHC revenue forecast at $369,038,013,771.
In 2027, SHC is forecast to generate $373,583,516,635 in revenue, with the lowest revenue forecast at $355,685,599,108 and the highest revenue forecast at $393,470,091,665.